Skip to content

Neuronetics STIM Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

LifeStance Health Group logo
LifeStance Health GroupLFST
LBR
LB Pharmaceuticals Inc Common StockLBRX
CVRx, Inc. logo
CVRx, Inc.CVRX
Stereotaxis logo
StereotaxisSTXS
Neuropace, Inc. logo
Neuropace, Inc.NPCE
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-56.2%
Enterprise value$162.64M-42.0%
P/S0.6×-1.3×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's operating lease right-of-use assets in other assets?
Neuronetics (STIM) reported operating lease right-of-use assets in other assets of $23.07M in Q1 2026.
How has Neuronetics's operating lease right-of-use assets in other assets changed year-over-year?
Neuronetics's operating lease right-of-use assets in other assets decreased by 13.6% year-over-year, from $26.7M to $23.07M.
What is the long-term trend for Neuronetics's operating lease right-of-use assets in other assets?
Over 5 years (2020 to 2025), Neuronetics's operating lease right-of-use assets in other assets has grown at a 47.1% compound annual growth rate (CAGR), from $3.42M to $23.56M.